Tags
Results for: Mulvaney Lab
-
Article Item
New cancer drug shows promise in targeting genetic weakness in tumors, Virginia Tech expert says , articleIn an invited review article in Cancer Discovery, a journal of the American Association for Cancer Research, Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute at VTC, talks about the potential of a new drug that has shown early promise in clinical trials for solid tumors by killing cancer cells that lack specific genes.
Date: Nov 01, 2023 -
Article Item
Common challenge, different strategies: Virginia Tech Cancer Research Alliance gathers broad mix of researchers and clinicians , articleThe second annual Virginia Tech Cancer Research Alliance retreat, hosted this year on the Children’s National Research & Innovation Campus, brought together scientists and physicians on the leading edge of developing innovative therapy types, fresh biological targets, and new technologies to take on cancer.
Date: Jun 21, 2023 -
Article Item
New cancer biologist targets ‘Achilles heel’ in deadly brain cancers , articleCancer biologist Kathleen Mulvaney joins the faculty of the Fralin Biomedical Research Institute at VTC on Oct. 1. Her lab will be in Washington, D.C., on the Children’s National Research & Innovation Campus as part of a partnership between Virginia Tech and Children’s National.
Date: Sep 27, 2022